RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE

RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE

Bibliografski detalji
Glavni autori:	Seeman, E, Chapurlat, R, Cheung, A, Felsenberg, D, La-Roche, M, Reeve, J, Thomas, T, Zanchetta, J, Bock, O, Morris, E, Tile, L, D'Alo, G, Darbie, L, Borah, B, Rizzoli, R
Format:	Journal article
Izdano:	2010

Slični predmeti

Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women.
od: Bala, Y, i dr.
Izdano: (2014)

Efficacy of risedronate in a post-menopausal woman affected by osteoporosis and inflammatory bowel disease
od: Stefano Palomba, i dr.
Izdano: (2010-06-01)

Risedronate or exercise for lean mass preservation during menopause: secondary analysis of a randomized controlled trial
od: Laura E. Flores, i dr.
Izdano: (2022-07-01)

Rapid and sustained effect of risedronate in reducing hip fracture risk in elderly women with osteoporosis.
od: Seeman, A, i dr.
Izdano: (2000)

Risedronate-loaded aerogel scaffolds for bone regeneration
od: Nahla El-Wakil, i dr.
Izdano: (2023-12-01)

Once-monthly risedronate for postmenopausal osteoporosis
od: Kristina Casadei, i dr.
Izdano: (2009-02-01)

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis
od: Raja Bobba, i dr.
Izdano: (2007-10-01)

Reversal deterioration of renal function accompanied with primary hypothyrodism
od: Dragović Tamara
Izdano: (2012-01-01)

The ROSI study (risedronate in adults with osteogenesis imperfecta type 1)
od: Duncan, E, i dr.
Izdano: (2005)

Efficacy of topical risedronate and risedronate - Eudragit E complex in a model of cutaneous leishmaniasis induced by Leishmania (Leishmania) amazonensis
od: Ma. Florencia Peralta, i dr.
Izdano: (2021-05-01)

Effect of risedronate on bone loss at discontinuation of denosumab
od: Michel Laroche, i dr.
Izdano: (2020-12-01)

Risedronate inhibits human osteosarcoma cell invasion
od: Jung Sung, i dr.
Izdano: (2009-07-01)

Preparation of Risedronate Nanoparticles by Solvent Evaporation Technique
od: Eliska Vaculikova, i dr.
Izdano: (2014-11-01)

An open‐label randomized study of the relative absorption of gastro‐resistant risedronate taken fasted or with food versus immediate‐release risedronate
od: Diane Kleinermans, i dr.
Izdano: (2022-06-01)

The Potential of Bisphosphonate Risedronate Hydrogel in Preventing Relapse Movement
od: Utari, Tita Ratya, i dr.
Izdano: (2022)

Evalution the Effects of Raloxifene and Risedronate on Serum Biochemical Markers
od: Abdurrahman Yeter, i dr.
Izdano: (2014-12-01)

Studies to elucidate the anti-tumor mechanism of action of risedronate in human myeloma cells; Use of an analogue of risedronate reveals the effects of differential inhibition of prenylation
od: Roelofs, A, i dr.
Izdano: (2005)

The Effect of Menopause on Antipsychotic Response
od: Alexandre González-Rodríguez, i dr.
Izdano: (2022-10-01)

Spectrophotometric Determination of Risedronate Sodium in Pharmaceutical Preparations by Derivative and Continuous Wavelet Transforms
od: Uğurlu, G., i dr.
Izdano: (2008-12-01)

Fluorescently labeled risedronate and related analogues: "magic linker" synthesis.
od: Kashemirov, B, i dr.
Izdano: (2008)

Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
od: Yohei Asada, i dr.
Izdano: (2019-01-01)

The Effects of Risedronate Treatment on the Pain and the Quality of Life - Original Investigation
od: Evrim Karadağ Saygı, i dr.
Izdano: (2009-08-01)

Development of Risedronate-Loaded Nano Capsules for Calvaria Healing in Rabbit
od: Hesam Aldin Hoseinzadeh, i dr.
Izdano: (2019-04-01)

Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
od: María J Moro-Álvarez, i dr.
Izdano: (2008-06-01)

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.
od: Sorensen, O, i dr.
Izdano: (2003)

Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.
od: Marma, MS, i dr.
Izdano: (2007)

Fluorescently labeled risedronate and related analogs: Design and evaluation as imaging probes
od: Coxon, F, i dr.
Izdano: (2008)

Fluorescently labeled risedronate and related analocs: Design and evaluation as imaging probes
od: Coxon, F, i dr.
Izdano: (2008)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
od: Tahir Masud, i dr.
Izdano: (2009-11-01)

Histomorphometric Effects of 2% Risedronate Gel on Calvarial Bone Defects in Rabbits
od: Shabnam Aghayan, i dr.
Izdano: (2021-03-01)

Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole
od: Vincenzo Monda, i dr.
Izdano: (2017-09-01)

The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model
od: Amy L. Inselman, i dr.
Izdano: (2024-04-01)

Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice.
od: Sugiyama, T, i dr.
Izdano: (2011)

Secondary Osteoporosis: Endocrine and Metabolic Causes of Bone Mass Deterioration
od: Tomasz Miazgowski, i dr.
Izdano: (2012-01-01)

The association between hormones and antipsychotic use: a focus on postpartum and menopausal women
od: Alexandre González-Rodríguez, i dr.
Izdano: (2019-07-01)

Fabrication and physicochemical characterization of porous composite microgranules with selenium oxyanions and risedronate sodium for potential applications in bone tumors
od: Kolmas J, i dr.
Izdano: (2017-08-01)

Effects of Risedronate and alendronate on colonic inflammation and bone loss in a mouse model of acute colitis
od: Brounais-Le Royer, B, i dr.
Izdano: (2012)

Rapid and sustained hip fracture risk reduction with risedronate in elderly women with osteoporosis
od: Cooper, C, i dr.
Izdano: (2001)

Crystal structures and molecular interactions of risedronate and zoledronate with human farnesyl diphosphate synthase
od: Kavanagh, K, i dr.
Izdano: (2006)

Alendronate and ibandronate affect osteoclast formation and size differently from risedronate and zoledronate
od: Mabilleau, G, i dr.
Izdano: (2011)